NLRP3 and hepatocellular carcinoma: Fan et al. (25) demonstrated that luteoloside defeats the proliferation and metastasis of HCC cells by inhibiting the NLRP3 inflammasome via decreasing the intracellular ROS (reactive oxygen species) in human neoplastic cell lines of the liver (Hep3B and SNU-449) and in an HCC animal model.